Arnav Mehta

Venture Partner at The Column Group

Arnav Mehta is a highly accomplished professional in oncology and biomedical research, currently serving as a Venture Partner at The Column Group since November 2024 and as a Visiting Scientist and Postdoctoral Researcher at the Broad Institute of MIT and Harvard since July 2020. Previous roles include Entrepreneur in Residence at Third Rock Ventures, where contributions were made to Clasp Therapeutics and various early-stage oncology and immunology projects, as well as positions in medical oncology at Massachusetts General Hospital and numerous consultancy roles across multiple pharmaceutical companies, including Flare Therapeutics and Asher Biotherapeutics. Arnav Mehta earned a PhD in Biology and Biological Engineering from Caltech, an MD from Duke University's medical school, and a BS in Chemistry and Mathematics from Duke University.

Location

San Francisco, United States

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices


The Column Group

1 followers

The Column Group (TCG) is a science-driven venture capital firm that makes significant financial and operational commitments to build early-stage drug discovery companies based on their unique scientific platforms and potential to deliver multiple breakthrough therapeutics.


Industries

Employees

11-50

Links